Vivian Hernandez-Trujillo, MD, FAAP

Medical Director, Division of Allergy & Immunology
Director, Allergy-Immunology Fellowship Program
Dr. Vivian Hernandez-Trujillo is a specialist in Allergy and Immunology. She has board certifications in both Pediatrics and Allergy/Immunology. She has over 20 years of experience caring for the most delicate patients.
Dr. Hernandez-Trujillo received her medical degree from Albany Medical College, New York and completed a three-year pediatric residency program at Miami Children’s Hospital. She completed her fellowship in Allergy and Immunology at the University of Tennessee, Memphis, St. Jude Children’s Research Hospital and Le Bonheur Children’s Medical Center.
Vivian Hernandez-Trujillo, MD, is a Clinical Professor at Florida International University Herbert Wertheim College of Medicine, in Miami, Florida. She serves as the Medical Director for the Division of Allergy and Immunology at Nicklaus Children's Hospital since 2008, along with starting and serving as the Program Director of the Allergy/Immunology Fellowship training program. She is founder of Allergy and Immunology Care Center of South Florida, which is part of the FARE clinical network.
Dr. Hernandez-Trujillo is a fellow of the American Academy of Pediatrics, American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma and Immunology.
Dr. Hernandez-Trujillo is interested in education regarding pediatric allergic disease, with particular interests in the topics of food allergy, anaphylaxis and primary immunodeficiency disorders. She lectures nationally and internationally on the topics of Pediatric Food Allergy, Anaphylaxis, and Immunodeficiency. Dr Hernandez-Trujillo has served on numerous committees for national organizations including executive committee member of the AAP Section of Allergy and Immunology, Allergy/Immunology representative to Council of Pediatric Subspecialties for the ACAAI, and currently serves on the Immune Deficiency Foundation Medical Advisory Board.
Dr Hernandez-Trujillo has served as principal investigator or co-principal investigator on a number of clinical studies on primary immunodeficiency, and has presented abstracts, posters, and lectures at meetings and conferences worldwide. She has published multiple articles in respected medical journals, co-edited the first two editions of the Board Review Textbook on Allergy/Immunology, is primary author of the chapter on B cell disorders and Antibody Deficiency Nelson’s Pediatrics and is author of the renowned UpToDate topic of Agammaglobulinemia.
Her most recent research and work has been in the areas of Healthcare disparities, particularly the impact on Hispanic/ Latinx patients. She was active during the COVID-19 pandemic sharing information in Spanish through efforts with the Immune Deficiency Foundation, participating in podcasts and panels about healthcare disparities in patients with primary Immunodeficiency, and collaborated with the Allergy and Asthma Network on a Webinar series for Hispanic/ Latinx patients and the impact of asthma. Her efforts to increase early solid food introduction include activities in collaboration with the American Academy of Pediatrics and speaking at national and international meetings about food allergy prevention, recognition and treatment.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:DBVTopic:Food allergyDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:US World MedsTopic:AnaphylaxisDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:KaleoTopic:AnaphylaxisDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:CovisTopic:AsthmaDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:TakedaTopic:ImmunodeficiencyDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:CSLTopic:ImmunodeficiencyDate added:Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:National peanut boardTopic:Peanut allergyDate added:05/06/2022Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:EnzyvantTopic:Thymic implantDate added:05/06/2022Date updated:05/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Regeneron/SanofiTopic:AsthmaDate added:05/06/2022Date updated:05/15/2024